ICH Generic Drug Harmonization May Be Another Cost-Lowering Opportunity

 
• By Derrick Gingery

The international group will work on harmonizing scientific and technical standards for generic drugs, which could reduce duplication and development costs.

businessman and businesswoman are shaking hands and exchanging folder after agreement was reached

More from Generics

More from Biosimilars & Generics